Purpose: Mesenchymal stem cells (MSCs) isolated from the anterior cruciate ligament (ACL) share multiple characteristics of bone marrowderived mesenchymal stem cells (BMSCs), allowing their use for regenerative therapies. Injuries to the ACL can affect people of all ages. This study assesses whether the regenerative potential of ACLderived MSCs (ACLMSCs) from old donors is as high as the potential of ACLMSCs from young donors. Materials and Methods: ACLMSCs were isolated from ACL tissues obtained from young and old donors at the time of ACL reconstruction or arthroplasty. Proliferative capacity, multilineage differentiation potential (chondrogenic, osteogenic, and adipogenic lineages), and transcriptomewide gene expression were assessed and compared between young and old donors. BMSCs of middleaged donors served as an additional comparator. Results: No substantial differences between ACLMSCs from young and old donors were observed in their proliferative capacity and multilineage differentiation potential. The latter did not substantially differ between both ACLMSC groups and BMSCs. Differential expression of genes related to the cytoskeleton and to protein dephosphorylation amongst other pathways was detected between ACLMSCs from young and old donors. Conclusions: Regenerative potential of ACLMSCs from old donors was not substantially lower than that from young donors, suggesting that regenerative therapies of ACL tears are feasible in both age groups. In vivo studies of the effect of age on the efficacy of such therapies are needed.
Introduction
A tear of the anterior cruciate ligament (ACL) is a common injury, which often requires surgical reconstruction using an au tologous tendon graft, e.g., the semitendinosus tendon 1) . In gen eral, successful ligament healing is achieved when the sequence of blood clot formation, invasion by leukocytes and fibroblasts, proliferation, extracellular matrix (ECM) molecule secretion, and tissue remodeling take place without disturbances 2) . Following an ACL injury, the high intraarticular activation of the fibrinolytic system disintegrates the blood clot too early to allow for invasion and ECM production of cells; and thereby permanently impedes successful healing 3) . When untreated, tears of the ACL can result in severe joint insta bility and facilitate the development of secondary meniscal tears and osteoarthritis, which necessitates the functional restoration 
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of the ligament 4) . ACL reconstruction, the surgical replacement of the torn ligament by an autologous tendon graft (e.g., semi tendinosus or patella tendon) is the current standard treatment 5) . Recent high level evidence suggests that current techniques of ACL reconstruction do not substantially improve patientreported outcomes 6) . On average, patients that received joint surgery due to an ACL injury are subject to total knee replacement 15 years ear lier than those with previous knee surgery not related to an ACL injury 7) . In order to improve outcomes after an ACL injury, novel regenerative therapies are being explored, which might allow res toration of the proprioceptive nerve functions of the native ACL obviating the harvest of an autologous tendon graft.
Tissue engineering approaches for the restoration of the ACL have been described, many of which use multipotent mesenchymal stem cells (MSCs) for several reasons. MSCs have been isolated from a variety of different tissues such as bone marrow, adipose tissue, trabecular bone, and tendon 8) . Research showed that cells isolated from torn ACLs of young donors possess a surface antigen expression profile highly similar to that of bone marrowderived mesenchymal stem cells (BMSCs) and they were able to undergo multilineage differentiation, which qualifies them as MSC types 9) . Thus, the use of ACLderived MSCs (ACLMSCs) for regenerative therapies of the injured ACL appears attractive. However, several studies have reported agedependent differences in the regenera tive capacities of BMSCs of differently aged donors 10) . Since injuries to the ACL can occur at both young and old age, it is necessary to define whether such regenerative approaches can be beneficial to both age groups. The objective of this study was to assess whether the regenerative potential of ACLMSCs from old donors (>60 years) is as high as the potential of ACLMSCs from young donors (<30 years). We specifically tested the hypothesis that ACLMSCs from old and young donors would be different regarding transcrip tomewide gene expression, proliferative capacity (colony forming unit [CFU] assay, cumulative population doubling times), and multilineage differentiation potential (chondrogenic, osteogenic, and adipogenic lineages). BMSCs of middleaged donors served as an additional comparator in the cell culture assays.
Materials and Methods
This study was approved by our University's Ethics Committee. Informed consent was obtained from all individual participants included in the study. 
Patient Characteristics and Tissue Collection

Isolation and Culture of ACL-MSCs
ACLMSCs were isolated using collagenase digestion 9) . Tissue specimens were minced into smaller pieces and digested in 12.5 U/µL collagenase NB4 (Serva Electrophoresis GmbH, Heidel berg, Germany) in complete medium consisting of Dulbecco's Modified Eagle Medium (DMEM)/Ham's F12 (PAA Laboratories GmbH, Coelbe, Germany), 10% fetal bovine serum (FBS, PAA Laboratories GmbH), 1% penicillin/streptomycin (PAA Labora tories GmbH) and 50 mg/mL Lascorbic acid 2phosphate (Sigma Aldrich GmbH, Taufkirchen, Germany) for 18 hours. The re leased cells were separated from tissue debris using a cell strainer, pelleted at 1,200 g for 5 minutes, resuspended in complete me dium, and seeded in 75 cm 2 flasks. For all subsequent differentia tion protocols, cells were cultivated in an incubator at 37°C and 5% CO 2 in a humidified atmosphere with media changes every 2-3 days. Cells were passaged using 1% trypsin (PAA Laborato ries GmbH) for 5 minutes for detachment, an equal volume of complete medium to stop the reaction, centrifugation at 1,200 g for 5 minutes to pellet cells, and resuspension in complete me dium, after which the cells were seeded at a minimal density of 5×10 3 per ml in cell culture flasks.
Isolation and Culture of Human BMSCs
BMSCs were isolated from 3 donors undergoing total hip re placement surgery (mean age 50 years). Trabecular bone was harvested from the femoral diaphysis and transferred to 50 mL canonical tubes containing 20 mL complete medium, vortexed and centrifuged at 1,200 g for 5 minutes. The fatty supernatant was carefully removed and pelleted cells were washed for five times in fresh complete medium. The washing medium was col lected, vortexed, and separated from remaining bony fragments using a cell strainer. Following centrifugation at 1,200 g for 5 minutes, the cells were resuspended in complete medium and plated at a density of at least 10 6 cells per mL in complete me dium in 175 cm 2 flasks. After three days, the adherent MSCs were washed with prewarmed phosphate buffer solution to remove nonadherent blood cells from the flasks. Subsequent culture was performed similarly to the culture of ACLMSCs.
Colony Forming Units-Fibroblasts Assay
A modified protocol of the CFUfibroblasts (CFUf) assay was used 11) . First passage ACLMSCs were seeded at a density of 200 cells per cm 2 in complete medium in 6 well plates. Medium was changed every 2-3 days for a total time of 10 days followed by the fixation of the cell layer with cold methanol for 10 minutes. CFU f colonies were detected by crystal violet staining for 5 minutes followed by three washing steps with phosphate buffer solution. The colonies were counted manually by four independent ob servers with an accumulation of at least 25 cells being counted as a single colony.
Cumulative Population Doublings
Cumulative population doublings were investigated in a long term culture system. Therefore, third passage cells were seeded at a density of 5×10 3 cells per cm 2 in three 25 cm 2 cell culture flasks for each cell donor and cultured in 5 mL complete medium. Once the monolayer became subconfluent, the cells were detached from the flasks using trypsin digestion, counted, and reseeded as described above. The procedure was repeated until no repeated increase in cell number could be detected or until a total time of 100 days in culture.
Chondrogenic Differentiation
Chondrogenic differentiation was performed in a pellet culture system, as previously described 12) . Third passage cells were de tached from the plastic surface of culture flasks using a trypsin digestion and counted, and 2.5×10 5 cells were transferred in 50 mL canonical tubes containing 500 µL of either chondrogenic or control media, followed by centrifugation at 1,500 g. Pellets were cultured in DMEM high glucose medium supplemented with 1% penicillin/streptomycin, 40 ng/mL Lproline, 50 ng/mL Lascorbic acid 2phosphate sesquimagnesium salt hydrate, 100 ng/mL pyruvate, 100 nM dexamethasone, 1% ITS (all SigmaAl drich, Schnelldorf, Germany), and human transforming growth factor (TGF)β1 (R&D Systems) for 28 days with the caps slightly opened to enable gas exchange. Control pellets were cultured in the absence of TGFβ1. Reverse transcription polymerase chain reaction (RTPCR) of the chondrocytespecific marker genes aggrecan core protein (ACAN), byglican (BGN), collagen alpha1(II) chain (COL2A1), cartilage oligomeric matrix protein (COMP), and fibromodulin (FMOD) were used to gauge the de gree of chondrogenic differentiation. Collagen alpha1(X) chain (COL10A1) was used to determine the degree of chondrocyte hypertrophy. Glycosaminoglycan (GAG) deposition was quanti fied using the Blyscan Glycosaminoglycan Assay kit (Tebubio, Offenbach, Germany) and histomorphometric quantification of alcian blue positive areas. Further, qualitative type II collagen im munohistochemistry was performed.
Osteogenic Differentiation
Osteogenic differentiation was performed in a monolayer cul ture system as previously described with slight modifications 12) . Confluent passage four donor cells were cultured in DMEM high glucose medium containing 10% FBS, 1% penicillin/streptomy cin, 10 ng/mL bone morphogenetic protein2 (kindly provided by Prof. Dr. Walter Sebald, Emeritus Chair of Physiological Chemis try, Faculty of Medicine, University of Wuerzburg, Germany), 10 mM βglycerophosphate, 50 ng/mL Lascorbic acid 2phosphate sesquimagnesium salt hydrate, and 100 nM dexamethasone (all Sigma Aldrich GmbH) for 28 days. Control cells were cultured in DMEM high glucose containing 10% FBS and 1% penicillin/ streptomycin only. RTPCR of the osteocytespecific marker gene alkaline phosphatase, tissuenonspecific isozyme (ALPL) and histomorphometric quantification of alkaline phosphatase (ALP) and alizarin red positive areas were performed to gauge the de gree of osteogenic differentiation.
Adipogenic Differentiation
Adipogenic differentiation was performed in a monolayer culture system according to a modified protocol described be fore 12) . Therefore, confluent fourth passage cells were incubated with DMEM high glucose containing 10% FBS, 1% penicillin/ streptomycin, 1 µg/mL insulin, 100 µM indomethacin, 0.5 mM 3isobutyl1methylxanthine, and 1 µM dexamethasone (all Sig ma Aldrich GmbH) for a total time of 21 days. Control cells were cultured in DMEM high glucose containing 10% FBS and 1% penicillin/streptomycin only. RTPCR of the adipocytespecific marker genes lipoprotein lipase (LPL) and peroxisome prolifer atoractivated receptor γ (PPARG), as well as the histomorpho metric quantification of oil red O positive areas were performed to gauge the degree of adipogenic differentiation.
RNA Isolation and RT-PCR
RNA from ACLderived cells was isolated using the NucleoSpin RNA II kit (MacheryNagel GmbH, Dueren, Germany) accord ing to the manufacturer's instructions. The pellets of chondro genic cultures were previously homogenized in the first buffer of the respective kit using a pestle. Then, 1 µg of isolated RNA was transcribed into cDNA using the BioScript kit (Bioline GmbH, Luckenwalde, Germany) with random hexamer primers (Life Technologies GmbH, Darmstadt, Germany) according to the manufacturer's protocols. Gene expression was analyzed using RTPCR with reaction mixtures containing 3 µL 10× reaction buffer (shipped with the MangoTaq from Bioline GmbH), 1 µL 10 mM dNTP mixture (Bioline GmbH), 1 µL of each forward and reverse primer corresponding to a concentration of 5 µM (Table 1) , and 3 µL MangoTaq polymerase (5,000 U/mL, Bioline GmbH), and 1 µL of cDNA in 21.9 µL distilled water. The PCR was started by an initial denaturation step at 94°C for 3 minutes followed by cycles of denaturation at 94°C for 45 seconds, primer annealing for 45 seconds with primer specific temperatures as il lustrated in Table 1 , and an elongation step at 72°C for 1 minute. Subsequent agarose gel electrophoresis was performed using 1.5% agarose gels (Merck) containing 0.5 µg/L ethidium bromide (AppliChem GmbH, Darmstadt, Germany) and 0.5×TBE buffer at 0.9 V/cm of gel length. Gels were documented photographi cally using the Bio Profile software (LTF, Wasserburg, Germany) and analyzed densitometrically using the GelAnalyzer software (http://www.gelanalyzer.com). For all targeted gene expression analyses, elongation factor 1alpha 1 (EEF1A1) was used as housekeeping gene.
GAG Expression
Pellets were digested using Papain (Sigma Aldrich GmbH) for 24 hours and resulting solution was used to determine the GAG 
Microchip Hybridization Experiments
First passage cells were used for the analysis of transcriptome wide gene expression. Denaturing agarose gel electrophoresis and photometrical methods were used to ensure the messenger RNA (mRNA) quality. Synthesis of complementary DNA, microchip hybridization, and signal detection were performed using the Af fymetrix GeneChipR 3'IVT express kit, the Affymetrix GeneChip expression analysis protocol ver. 2, the GeneChip scanner 3000 with the operating software GeneChip 1.2 (all Affymetrix). Us ing the comprehensive R based microarray analysis web frontend CARMAweb, the generated raw data were normalized by the guanine cytosine robust multiarray analysis (GCRMA) algo rithm 13, 14) . Afterwards, the values for the three biological repli cates of each group were merged calculating the arithmetic mean for each probe followed by the determination of the relative fold change comparing the two age groups. Applying the moderated t statistics included within the bioconductor package, linear mod els for microarray data (limma), and the BenjaminiHochberg method for correction for multiple hypothesis testing, the statisti cal significance of the computed data was tested 15, 16) . The result ing list of probesets was filtered by discarding those that were not associated with a specific gene, had a fold change between 0.5 to 2.0, or a p>0.05. The remaining probesets and their correspond ing genes were either grouped into positively or negatively regu lated genes and used for pathway enrichment analysis using the gene ontology enrichment analysis and visualization tool Gorilla and the Gene Ontology (GO) Consortium's annotation and on tology toolkit AmiGO 17, 18) . A list of all detectable genes was used as a background list. We filtered the resulting GO terms, and we discarded GO terms with less than 5% differentially regulated genes or small GO terms being represented by <3.
Statistical Analysis
The Student ttest was utilized to test for significant differences in the CFU assay, the population doubling times, the histomorpho metric analyses, densitometric RTPCR analyses, GAG contents, DNA contents, and the ATP activities. pvalues below 0.05 were considered statistically significant. Three independent samples from each group, each with technical triplicates, were used for all appli cable assays; with exception to the CFUf assay (young, n=5; old, n=6) and cumulative population doubling (young, n=2; old, n=4). 
Results
ACL-MSCs from Young Donors Have a Greater Amount of Surface Antigens Characteristic for MSCs than ACL-MSCs from Old Donors
Characterization of ACLMSCs from young and old donors by tissue properties and surface antigens show differences in histo logical and immunohistochemical examinations (Figs. 1 and 2 ).
The Transcriptome-Wide Analysis Reveals Differential Gene Expression Patterns between ACL-MSCs from Young and Old Donors
Comparing ACLMSCs from young and old donors, 561 probe sets were found to be upregulated in the cells from young donors (Top 10 genes in Fig. 3A) . The corresponding genes encompassed ECM molecules (such as COL1A1, COL5A1, COL6A1, and BGN amongst others) or growth factors (such as TGFB1) and enriched 16 terms in the GO biological process, 1 term in the GO biologi cal function and 7 terms in the GO cellular component ontolo gies (Fig. 3B) . These terms were mainly associated with protein dephosphorylation and components of the cytoskeleton (Fig.  3B) . Further, 613 probesets were upregulated in cells from old donors, when compared to young donors. The corresponding genes encompassed genes encoding for proteins that are involved in ossification processes (such as PDE1A, EREG, and SFRP1) or osteoarthritis (such as CTNNB1) and enriched 8 terms in the GO biological process and 3 terms in the GO biological function on tologies. Those were mainly related to nuclear transport, protein kinase B activity, epithelialmesenchymal cell signaling, and the activity of RNA polymerase II cofactor (Fig. 3B) .
The Proliferative Capacity of ACL-MSCs Does Not Differ between Young and Old Donors
The CFUf frequency ranged from 0.005 to 0.3 with no distinct agedependent distribution pattern being detectable (Fig. 4A) . Similarly, no distinct agedependent differences in the cumulative population doublings were observed. However, ACLMSCs from two old donors entered growth arrest after approximately 80 days 
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in culture (Fig. 4B) . When compared to BMSCs, ACLMSCs of both groups did not show a distinct difference (Fig. 4B ).
ACL-MSCs from Young and Old Donors Do Not Differ in Their Potential for Chondrogenic Differentiation
ACLMSCs from both age groups responded with a strong increase in alcian blue staining, when cultivated as pellets in the presence of TGF beta1, comparable to BMSCs (Fig. 5A-C) . Likewise, the GAG content normalized to the DNA content increased in both ACLMSC groups, when comparing induced versus control pellets. However, the normalized GAG content was generally higher in control and induced ACLMSCs from young donors than in those obtained from old donors (Fig. 5D ). All groups expressed the articular cartilage marker COL2A1, as well as the hypertrophy marker COL10A1 (Fig. 5E) , resulting in the deposition of type II collagen in the superficial zones of the induced pellets (Fig. 5A) . The staining intensity was highest in the ACLMSCs from young donors, mildly reduced in ACL MSCs from old donors, and even further reduced in BMSCs. These differences were not substantial (Fig. 5A) . In the analysis of proteoglycan expression, the upregulation of ACAN expres sion after chondrogenic induction was lower in the ACLMSCs from old donors than in those from young donors or in BMSCs, but this finding did not reach the level of statistical significance (p>0.05). No difference in the upregulation of BGN expression was observed (Fig. 5F ).
ACL-MSCs from Young and Old Donors Do Not Differ in
Their Potential for Osteogenic Differentiation After osteogenic induction, ACLMSCs from both age groups showed an increased ALP activity, comparable to BMSCs (Fig.  6A) . Likewise, a strong production of mineralized ECM was detected, without any detectable difference between ACLMSCs from young and old donors (Fig. 6A) . Qualitatively, both ACL MSC groups produced less mineralized ECM than BMSCs (Fig.  6A) . However, no significant difference was detected after histo morphometric quantification (Fig. 6D) . On the level of mRNA expression, a strong increase in ALP expression was detected in both ACLMSCs from young and old donors (Fig. 6B) . As BMSCs show a relatively high expression of ALP in uninduced control cells (Fig. 6A and B) , the increase in gene expression after osteogenic induction is smaller than the increase observed in both ACLMSCs (p>0.05).
Their Potential for Adipogenic Differentiation After adipogenic induction, ACLMSCs from young and old donors synthesized lipid droplets (Fig. 7A) . A slightly higher amount of lipid droplets was detected in ACLMSCs from old donors when compared to young donors, but this effect was not considered significant (p>0.05) (Fig. 7B) . Both ACLMSC groups produced significantly less lipid droplets than the induced BM SCs. On the level of mRNA expression, the presence of adipo genic medium induced the expression of the adipocyte marker genes LPL and PPARG in all groups (Fig. 7C) . 
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differences in proliferative capacity (assessed using the CFUf as say and cumulative population doubling times) and potential for multilineage differentiation (chondrogenic, osteogenic, and ad ipogenic lineage) were observed. However, in the transcriptome wide analysis of gene expression, the differential expression of several genes was detected in the comparison of ACLMSCs from young and old donors, which enriched several pathways related to protein dephosphorylation, cytoskeleton, or protein kinase B activity. The different gene expression patterns in first passage ACLMSCs of both age groups did not significantly impact the subsequently performed in vitro proliferation and multilineage differentiation. We examined the agedependent regenerative capacity of ACLMSCs. The obtained results indicate that ACLMSCs can be isolated from old donors (up to 79 years) with knee osteo arthritis and be used for regenerative therapies. A recent study also showed comparable phenotypes and multilineage poten tials between ACLMSCs derived from young and old donors, supporting our results 17) . In contrast to our study, they found a greater proportion of MSCs in young patients than in older patients at initial isolation of MSCs, while in further cell pas sages, the proportions of MSCs from young and older patients were without differences in both studies 17) . This study supports our findings that ACLMSCs from young and old donors have similar potentials for multilineage differentiation, but differences in gene expression could be detected, which might contribute to a different cytoskeleton and ECM 17) . In contrast to Lee et al. 17) and our presented study, Uefuji et al. 19) found not only a higher proportion of MSCs but also a higher potential for proliferation and multilineage differentiation of MSCs from young donors than MSCs from older donors in vitro. These findings might be important for native tissue healing potential in vivo, but as we and others showed, MSCs from older donors probably can be used for the development of regenerative therapies as MSCs from younger donors 17) . However, our study has limitations. One such limitation is the use of in vitro assays, as it is currently not possi ble to define an effect size at which an observed difference would translate into a meaningful difference on in vivo application. It is likely that some of the slight differences observed here would reach the level of statistical significance when more independent samples were included. However, existing studies assessing ten donderived MSCs, or BMSCs from healthy patients and patients with osteoarthritis did not document agedependent differences in CFUf frequencies either 20, 21) . Other studies showed slight age dependent differences in CFUf formation for BMSCs isolated from young and old donors, but none of them was statistically significant 19, 22) . Likewise, no significant agedependent difference in the cumulative population doublings was observed, which is in accordance with some published characterizations of BMSCs 23, 24) . High donor variability for human BMSCs was demonstrated previously, suggesting that other patientspecific factors might influence the regenerative potential of MSCs to a greater extent than age 2527) . The present study cannot isolate age effects and the effects of acute ACLinjury and knee osteoarthritis, as all young donors were subject to knee injury and all old donors received a total knee replacement due to osteoarthritis. This might explain the findings of the transcriptomewide gene expression analysis obtained in the present study. Higher expression of ligament ECM molecules in first passage ACLMSCs (such as COL1A1, COL5A1, COL6A1, and BGN amongst others) or growth factors (such as TGF B1) was observed in young donors, while old do nors demonstrated the upregulation of genes related to ossifica tion (such as PDE1A, EREG, and SFRP1) and osteoarthritis (such as CTNNB1) 2830) . In both conditions, older age and osteoarthritis, a lower regenerative capacity of ACLMSCs would be expected in in vitro assays. The finding that ACLMSCs obtained from young donors without a chronic joint disease are not substantially more potent than ACLMSCs obtained from old donors with chronic osteoarthritis makes the conclusion of this study more versatile. ACLMSCs can be derived from ligaments of young and acutely injured, as well as from old patients with chronic osteoarthritis and be used for regenerative therapies that require capacity to proliferate and the potential to differentiate along multiple mes enchymal lineages. However, future in vivo studies need to assess whether agedependent differences can be detected in the respec tive application of ACLMSCs.
Conclusions
In the conducted examinations, the regenerative potential of 
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ACLMSCs from old donors was not substantially lower than that from young donors, suggesting that the use of these cells for regenerative therapies is feasible in both age groups. These find ings may be of considerable use for those developing regenerative therapies for the ACL or other knee joint tissues, which could be augmented with MSCs.
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